Author
Listed:
- Sumaira Omer
(Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China
Center for Drug Safety and Policy Research, Xian Jiaotong University, Xi’an 710061, China
Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China
Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China)
- Salamat Ali
(Department of Pharmacy, Quaid-i-Azam University, Islamabad 45320, Pakistan)
- Sundus Shukar
(Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China
Center for Drug Safety and Policy Research, Xian Jiaotong University, Xi’an 710061, China
Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China
Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China)
- Ali Hassan Gillani
(Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China
Center for Drug Safety and Policy Research, Xian Jiaotong University, Xi’an 710061, China
Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China
Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China)
- Yu Fang
(Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China
Center for Drug Safety and Policy Research, Xian Jiaotong University, Xi’an 710061, China
Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China
Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China)
- Caijun Yang
(Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China
Center for Drug Safety and Policy Research, Xian Jiaotong University, Xi’an 710061, China
Shaanxi Centre for Health Reform and Development Research, Xi’an 710061, China
Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710061, China)
Abstract
Managing medicine shortages consumes ample time of pharmacists worldwide. This study aimed to explore the strategies and resources being utilized by community pharmacists to tackle a typical shortage problem. Qualitative face-to-face interviews were conducted. A total of 31 community pharmacists from three cities (Lahore, Multan, and Dera Ghazi Khan) in Pakistan were sampled, using a purposive approach. All interviews were audio taped, transcribed verbatim, and subjected to thematic analysis. The analysis yielded five broad themes and eighteen subthemes. The themes highlighted (1) the current scenarios of medicine shortages in a community setting, (2) barriers encountered during the shortage management, (3) impacts, (4) corrective actions performed for handling shortages and (4) future interventions. Participants reported that medicine shortages were frequent. Unethical activities such as black marketing, stockpiling, bias distribution and bulk purchasing were the main barriers. With respect to managing shortages, maintaining inventories was the most common proactive approach, while the recommendation of alternative drugs to patients was the most common counteractive approach. Based on the findings, management strategies for current shortages in community pharmacies are insufficient. Shortages would continue unless potential barriers are addressed through proper monitoring of the sale and consumption of drugs, fair distribution, early communication, and collaboration.
Suggested Citation
Sumaira Omer & Salamat Ali & Sundus Shukar & Ali Hassan Gillani & Yu Fang & Caijun Yang, 2021.
"A Qualitative Study Exploring the Management of Medicine Shortages in the Community Pharmacy of Pakistan,"
IJERPH, MDPI, vol. 18(20), pages 1-13, October.
Handle:
RePEc:gam:jijerp:v:18:y:2021:i:20:p:10665-:d:654007
Download full text from publisher
References listed on IDEAS
- Heiskanen, K. & Ahonen, R. & Karttunen, P. & Kanerva, R. & Timonen, J., 2015.
"Medicine shortages – A study of community pharmacies in Finland,"
Health Policy, Elsevier, vol. 119(2), pages 232-238.
- Said, André & Goebel, Ralf & Ganso, Matthias & Zagermann-Muncke, Petra & Schulz, Martin, 2018.
"Drug shortages may compromise patient safety: Results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists,"
Health Policy, Elsevier, vol. 122(12), pages 1302-1309.
- Emily Chen & Susan Goold & Sam Harrison & Iman Ali & Ibtihal Makki & Stanley S Kent & Andrew G Shuman, 2021.
"Drug shortage management: A qualitative assessment of a collaborative approach,"
PLOS ONE, Public Library of Science, vol. 16(4), pages 1-13, April.
Full references (including those not matched with items on IDEAS)
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
- Vogler, Sabine & Fischer, Stefan, 2020.
"How to address medicines shortages: Findings from a cross-sectional study of 24 countries,"
Health Policy, Elsevier, vol. 124(12), pages 1287-1296.
- Said, André & Goebel, Ralf & Ganso, Matthias & Zagermann-Muncke, Petra & Schulz, Martin, 2018.
"Drug shortages may compromise patient safety: Results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists,"
Health Policy, Elsevier, vol. 122(12), pages 1302-1309.
- Vogler, Sabine, 2024.
"Tackling medicine shortages during and after the COVID-19 pandemic: Compilation of governmental policy measures and developments in 38 countries,"
Health Policy, Elsevier, vol. 143(C).
- Guilcher, Sara & Munce, Sarah & Conklin, James & Packer, Tanya & Verrier, Molly & Marras, Connie & Bereket, Tarik & Versnel, Joan & Riopelle, Richard & Jaglal, Susan, 2017.
"The financial burden of prescription drugs for neurological conditions in Canada: Results from the National Population Health Study of Neurological Conditions,"
Health Policy, Elsevier, vol. 121(4), pages 389-396.
- Kati Heiskanen & Riitta Ahonen & Risto Kanerva & Pekka Karttunen & Johanna Timonen, 2017.
"The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland,"
PLOS ONE, Public Library of Science, vol. 12(6), pages 1-14, June.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:20:p:10665-:d:654007. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.